PrEP (pre-exposure prophylaxis), a drug that prevents HIV transmission upon exposure, is a crucial aspect of HIV prevention. However, not everyone who may benefit from PrEP can access it—some may not even know what PrEP is. Women remain a group that is significantly underrepresented among PrEP users. Although women account for 20% of new HIV diagnoses, less than 10% of women in the US who could benefit from PrEP end up getting a prescription for PrEP.